National Cardiogenic Shock Initiative (CSI) Protocol
Sites participating in the National Cardiogenic Shock Initiative (CSI) have adopted the National CSI algorithm as the foundatio...
Renal Protection During Impella®-Supported PCI in Patients With High-Risk Complex Coronary Artery Disease
Protected PCI with Impella lowers the incidence of AKI when compared to high-risk PCI in ECMO-supported patients and demonstrat...
Current PCI Landscape and Opportunities for Improvement
An overview of the landscape, contemporary data, quality measures, and technologic trends that will guide complex CAD cases tow...
Using Impella CP® with SmartAssist® to Guide Successful Weaning in High-Risk PCI Procedure
IMP-1360...
High-Risk PCI Involving Chronic Kidney Disease, PVD and LV-dysfunction
Dr. Flaherty presents a case review of an 85-year-old male who presented with unstable angina symptoms, multivessel coronary ar...
Clinical Dossier Protected PCI with Impella®
The 2020 Clinical Dossier: Protected PCI with Impella® is a collection of data and clinical evidence supporting the use of Impe...
WellStar Hub and Spoke Cardiogenic Shock Treatment Network
Successful Implementation of Cardiogenic Shock Algorithm Dr. Salvatore Mannino discusses the...
Impella Patient Systemic IV Heparin Rate Calculator
Anticoagulation Therapy with Impella® Heparin Infusion NPS-359 v3...
Allegheny Health Network Protected PCI Algorithm
Download the Allegheny Health Network Protected PCI Algorithm to guide decision-making for appropriate use of the Impella® hear...
New Data from NCSI Demonstrates 72% Survival with 98% Native Heart Recovery
New data from the National Cardiogenic Shock Initiative Study (NCSI) on 171 consecutive AMI cardiogenic shock (AMICS) patients...
For Best Outcomes in AMI Cardiogenic Shock, Place Impella 2.5® or Impella CP® Pre-PCI
A preponderance of evidence from the FDA cVAD Study, Impella Quality Assurance Database and physician-initiated National Cardio...
Impella RP® Heart Pump Patient Selection Criteria Checklist
Use this checklist to guide treatment decisions and determine if the Impella RP is right for your patients. IMP-796 v3...
Dr. O’Neill’s IQ Data and AMICS Presentation from TCT 2018
Adoption of best practices improves survival for patients with Acute Myocardial Infarction and Cardiogenic Shock (AMICS) suppor...
Renal Effects of Impella Support During Protected PCI
Dr. Michael P. Flaherty's TCT 2018 presentation on Renal Effects of Impella support during Protected PCI....
Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device
Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) data...
Step-by-Step Guide to Left Heart Unloading with Impella 5.0®
The Impella 5.0 is approved for use in cardiogenic shock, and is proven to unload the left ventricle and support the systemic c...
Mt. Sinai Protected PCI Algorithm
Download the Mt. Sinai Protected PCI Algorithm to guide decision-making for appropriate use of the Impella 2.5 and Impella CP h...
Impella Quick Reference and Troubleshooting Guide
Impella 2.5/Impella CP/Impella 5.0/Impella LD/Impella RP Heart Pumps - Quick Reference and Troubleshooting Guide For AIC Softwa...
Complex PCI with Multiple Comorbidities
Dr. Tanveer Rab of Emory University joins Dr. Cathy Jeon to discuss a case of an 80 year old male with a low ejection fraction...
Henry Ford Algorithm
This is a sample high-risk PCI algorithm used by Henry Ford Health System. Specifically, it is a Left Ventricular Mechanical Ci...
Impella® Program Protocol and Tools
The Impella® Program Protocol and Tools Provides Resources on Impella Best Practices Including:Data-driven protoc...
Estimating Impella 5.0/LD Flow from Motor Current
Abiomed has observed that when clinicians encounter an unreliable differential pressure sensor while a patient is being support...
